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1. Introduction 
In the Western World, the public perception of advanced aging involves the inability to 
survive due to chronic diseases and the combined loss of mobility, sensory functions, and 
cognition with an exponential growth of health costs. Therefore, biomarkers of human aging 
are urgently needed to assess the health state of elderly and the possible therapeutic 
interventions. Aging is considered a process that changes the performances of most 
physiological systems and increases susceptibility to diseases and death. The aging 
phenotype is a complex interaction of stochastic, environmental, genetic and epigenetic 
variables. However, these variables do not create the aging phenotype but favour the lost of 
molecular fidelity and therefore as the random accumulation of damages in the human 
organism's cells, tissues, or whole organism during life increases, the probability of disease 
and death also augments in proportion (Candore et al., 2008). What a biomarker for aging 
should be or predict is quite broadly defined. A biomarker should not only (i) reflect some 
basic property of aging, but also (ii) be reproducible in cross-species comparison, (iii) change 
independently of the passage of chronological time (so that the biomarker indicates 
biological rather than chronological age), (iv) be obtainable by non invasive means, and (v) 
be measurable during a short interval of life span. A biomarker should reflect the 
underlying aging process rather than disease (Warner et al., 2004). In addition, a set of 
biomarkers should be based on mechanisms described by major theories of aging. A 
sustained number of biomarkers are currently under investigation, such as inflammatory 
markers, markers of oxidative stress or markers of telomere shorthening but the definition 
of biomarker is strictly related to the understanding of the mechanisms of aging and we 
might not be able to define an ideal biomarker yet. Moreover, the biomarkers of aging 
discussed in literature, are associated not only to age but also to diseases Accordingly, it is 
crucial to monitor basic mechanisms that underlies the aging process. Noteworthy, a recent 
study reported that biomarkers of cardiovascular diseases (CVD) and diabetes are useful 
predictors of healthy aging (Crimmins et al., 2008). 
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Another problem, which is probably even more challenging, is to understand if a biomarker 
validated for rodents could be applied equally to humans. 
Notably, it should be highlighted that mammalian cells have developed highly refined 
inducible systems against a variety of stressful conditions; upon stimulation, each one of 
these systems can be engaged concertedly to alleviate and hinder the manifestation of a 
distinctive age-related disorder. In this context, increasing scientific evidence supports a 
pivotal role for the heat shock proteins in the protection against oxidative stress and 
inflammation. Heat shock response is a fundamental cellular survival pathway, involving 
both transcriptional and post-trascriptional regulation. The impairment of this regulatory 
mechanism might directly contribute to the defective cellular stress response to oxidative 
stress and deregulation of inflammatory processes, which characterizes senescence. 
In the present chapter, we will focus on the importance of biomarkers involved in 
inflammatory responses, oxidative stress but also markers based on immunosenescence. 
Additionally, we will describe the major experimental methods that are available in 
biogerontology for the interpretation of the aging phenotypes.  In summary, we will present 
an overview on the current knowledge of the complex molecular and biological events 
leading to cellular senescence and how we can measure this progression to possibly 
improve our quality of life. 
2. Aging and the immune system 
Aging is accompanied by a general dysregulation in immune system function, commonly 
referred to as immunosenescence. This progressive deterioration affects both innate and 
adaptive immunity, although accumulating evidence indicates that the adaptive arm of the 
immune system may exhibit more profound changes. Most of our current understanding of 
immune senescence stems from clinical and rodent studies. Studies have suggested that 
aging is associated with increase permeability of mucosal barriers, decreased phagocytic 
activity of macrophages and dendritic cells (DCs), reduced natural killer (NK) cell 
cytotoxicity, and dysregulated production of soluble mediators such as cytokines and 
chemokines (Weiskopf et al., 2009). These alterations could lead to increased pathogen 
invasion and poor activation of the adaptive immune response mediated by T and B-
lymphocytes. The age-related changes which occur in the adaptive and innate immune 
response are summarized in Table 1. 
Aging, is also associated with quantitative and qualitative changes within the naive  
CD4+T-cell compartment (Aspinall & Andrew, 2000; Fulop et al., 2006; Kilpatrick et al., 
2008). Decreased numbers of recent thymic emigrants (RTE), shortened telomeres, 
hyporesponsiveness to stimulation, decreased proliferative capacity, reduced IL-2 
production, alterations in signal transduction and changes in cell surface phenotype 
(Whisler et al, 1996; Fulop et al., 2006; Kilpatrick  et al., 2008) have all been reported. These 
changes likely contribute to the poor response to vaccines and increased susceptibility to 
infectious diseases and neoplasms reported for older adults (Webster, 2000; Effros, 2000; 
Herndler-Brandstetter  et al., 2006). 
Aging causes a shift in the ratio of naive to memory T-cells, with associated changes in the 
cytokine profile that favor increases in pro-inflammatory interleukin-1ǃ (IL-1ǃ), interleukin-
6 (IL-6), interferon Ǆ (IFNǄ), tumor necrosis factor (TNFǂ), and transforming growth factor 
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(TGFǃ) (Sansoni et al., 2008). The production of IL-6, but not IL-1ǃ or TNF-ǂ, by peripheral 
blood mononuclear cells increases in the elderly (Roubenoff et al., 1998), and IL-1ǃ 
production increases in peripheral blood mononuclear cells in older animals (Chung et al., 
2006). In contrast, IL-1ǃ levels are higher and IL-6 levels lower in the livers of old rats than 
young rats (Rikans et al., 1999). 
As the hematopoietic system ages, the immune function deteriorates, the lymphoid potential 
diminishes, and the incidence of myeloid leukemia increases (Rossi et al., 2005). Aging leads 
to increased stem cell dysfunction, and as a result leukemia can develop in failed attempts 
by the bone marrow to return to a homeostatic condition after stress or injury. Stem cells 
leave the hibernation state and undergo self-renewal and expansion to prevent premature 
hematopoietic stem cell (HSC) exhaustion under conditions of hematopoietic stress (Walkey 
et al., 2005). HSCs in older mice produce a decreased number of progenitors per cell, 
decreased self-renewal and increased apoptosis with stress (Janzen et al., 2006).  
The remaining stem cells divided more rapidly as if to compensate for those that were lost. 
Stimulating old stem cells to grow more rapidly, perhaps by stress such as infrared (IR), 
puts stem cells at greater risk of becoming cancer cells because of acquired DNA damage. 
Metabolically active senescent cells, identified by the biomarkers of cellular aging, such as 
the ┛-H2AX foci and perhaps the senescence-associated ǃ-galactosidase (SA-ǃ-gal) enzyme, 
accumulate in aging primates (Herbig et al., 2006). Cellular senescence can be induced in 
one of two ways. Firstly, reactive oxygen species (ROS) may contribute to the plentiful 
single-strand breaks (SSBs) and double-strand breaks (DSBs) present in senescent cells 
(Sedelnikova et al., 2004); this is a form of telomere-independent stress-induced senescence. 
Alternatively, telomere-dependent uncapping of telomere DNA causes replicative 
senescence. An increase in oxidative stress is a more probable cause of HSC senescence than 
telomere erosion (Beauséjour et al., 2007). High doses of IR lead to apoptosis of HSCs, while 
lower doses cause HSCs to senesce and lose the ability to clone themselves (Wang et al., 
2006). Furthermore, irradiated normal human fibroblasts and tumor cell lines can also lose 
their clonogenic potential and undergo to accelerated senescence (Mirzayans et al., 2005). 
The inhibition of tumorigenesis by cellular senescence is oncogene-induced and linked to 
increased expression of tumor suppressor genes cyclin-dependent kinase inhibitor 2A 
(p16INK4a or CDKN2A) and tumor protein 53 (TP53) via the DNA damage response 
(Bartkova et al., 2006). Recent research points to the p16INK4a protein being an important 
aging biomarker as its concentrations in peripheral blood exponentially increase with 
chronological age, reducing stem cell self-renewal (Liu et al., 2009). The few articles 
published to date linking radiation’s health effects and p16INK4a can be paradoxical with 
regard to aging. A Chinese study showed the cumulative radiation dose of radon gas among 
uranium miners to be positively associated with the aberrant promoter methylation and 
inactivation of the p16INK4a and O6-methylguanine-DNA methyltransferase (MGMT) genes in 
sputum, perhaps indicating the early DNA damage and a greater susceptibility to lung 
cancer (Su et al., 2006). 
The number and proliferation potential of stem cell populations, including those of the 
intestinal crypt and muscle, decrease with age, leading to a progressive deterioration of 
tissue and organ maintenance and function (Schultz et al., 1982; Martin et al., 1998). 
Macromolecular damage in general and DNA damage in particular, accumulate in HSCs 
with age (Rossi et al., 2007). The reduced ability to repair DNA DSBs leads to a progressive 
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loss of HSCs and bone marrow cellularity during aging (Nijnik et al., 2007). In addition, high 
radiation dose (>12.5 Gy) from 45Ca, a bone-targeting beta-ray emitter (Barranco et al., 
1969), resulted in marked reduction in marrow cellularity, similar to the one observed in 
normal aging indicating a possible contribution of the DNA–repair mechanisms to the aging 
process.  
 
 
     
Table 1. Age-related changes in the innate and adaptive immune system. 
3. Oxidative stress and inflammation as causes of aging 
To date, there are several theories which attempt to explain the process of aging, such as 
telomere theory, caloric restriction, and evolutionary theory. The oxidative stress 
hypothesis/free radical theory of aging, updated by Harman in 2006 (Harman, 2006) offers a 
possible biological explanation of the entire aging process. In a biological context, a 
condition of oxidative stress occurs when there is an imbalance between oxidant molecules 
and antioxidant defensive molecules. Such critical balance is disrupted when antioxidants 
are depleted or if the formation of ROS increases beyond the ability of the antioxidative 
systems. Additionally, the free radical theory proposed that the production of intracellular 
ROS is the major determinant of life span. 
However, the most critical problem is to find a correlation between oxidative biomarkers 
amounts and human health. Nevertheless, according to the free radical theory of aging, 
oxidative stress increases with increasing age resulting in oxidative DNA damage, protein 
oxidation and lipid peroxidation.  
One of major risk markers of oxidative damage of nucleic acids is the 8-hydroxy-29- 
deoxyguanosine (8-OHdG). So far, 8-OHdG is the most studied oxidative DNA lesion and it 
is formed when ROS act on deoxyguanine in DNA (Ravanat et al., 2000). 8-OHdG can alter 
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gene expression, inhibits methylation and its mutagenic potential leads to GC → AT 
conversion. The formation of 8-OHdG in leukocyte DNA and the excretion of 8-OHdG into 
urine have been frequently measured to assess oxidative stress in humans. However, even 
though interesting results have been obtained with 8-OHdG, several studies have associated 
aging with a progressive loss of antioxydant defence.  
Recently, several findings have emphasized the importance of lipid peroxidation in relation 
to the role of caloric restriction and the extension of longevity (Sanz et al., 2006). Lipid 
peroxidation products have also been shown to be mutagenic and carcinogenic and has been 
implicated as the underlying mechanisms in numerous disorders including aging. Notably, 
lipid oxidation not only causes membrane disruption but also produces aldehydic species, 
such as malondialdehyde (MDA), able to perpetrate further damage by binding to and 
modifying proteins. Although producing contradictory results, the measure of lipid 
peroxidation is an example of biomarkers of oxidative stress. The measurement of MDA is 
very easy to perform, fast and not expensive. MDA is often utilized to evaluate human 
aging and in numerous studies MDA was significantly higher in healthy elderly, confirming 
the presence of increased lipoperoxidation in old age.  
Another important product generated by lipid peroxidation is 4-hydroxy-2-nonenal (HNE) 
that reacts with nucleic acids, proteins, and phospholipids inducing many cytotoxic, 
mutagenic, and genotoxic effects (Uchida, 2003). Low-density lipoproteins (LDL) seems to 
be another good marker because oxidised LDL appears to be involved in the development 
of various pathological conditions aging related. Measurements of LDL could be obtained in 
vivo by measuring oxidised LDL particles in blood using immunological methods with 
appropriate specificity.  
In addition, phosphatidylcholine hydroperoxides (PCOOH) measured in blood or tissue is 
also an acceptable marker of lipid peroxidation. 
Recently, isoprostanes (IsoPs), compounds that are produced in vivo by free radical-induced 
peroxidation of arachidonic acid, have been also proposed to assess the oxidative stress 
status but we have only few experimental evidence and convincing outcomes have not 
emerged yet (Montuschi et al., 2007). Particularly, the analysis of F2-isoprostanes has 
revealed a role for free radicals and oxidant injury in a wide variety of human diseases. 
However, it must be taking into account that the measurement of F2-isoprostanes represents 
a snapshot of oxidant stress at a discrete point in time. Indeed, F2-isoprostanes are cleared 
rapidly from the circulation. However, such molecules that are stable isomers of 
prostaglandin F2, seems to be the best reliable marker and it has been proposed as most 
affidable index of systemic or “ whole body” oxidative stress over time. 
Closely related to oxidative stress is the protein oxidation. The main molecular characteristic 
of aging is the progressive accumulation of damages in macromolecules and age related 
damage in proteins have been reported in cells, tissues and organs (Rattan, 2006). The 
measurement of the protein oxidation is a clinically important factor for the prediction of the 
aging process and age-related diseases. The most widely studied oxidative stress-induced 
modification to proteins is the formation of carbonyl derivatives. Carbonyl formation can 
occur through a variety of mechanisms including direct oxidation of certain amino-acid side 
chains and oxidation-induced peptide cleavage. Furthermore, advanced oxidation protein 
products considered as biomarkers to estimate the degree of oxidative modifications of 
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proteins and carbonyl groups may be introduced into proteins by reactions with aldehydes, 
reactive carbonyl derivatives or through their oxidation products with lysine residues of 
proteins. Although all organs and all proteins can potentially be modified by oxidative 
stress, certain tissues and specific protein may be especially sensitive. For istance, recent 
studies characterized oxidatively modified proteins in the brain and identified specific 
proteins that are oxidatively modified in Alzheimer’ s disease (Butterfield & Sultana, 2007). 
Aging is accompanied by chronic low-grade inflammation status and inflammatory 
mediators may be usefull to monitor aging processes. Molecular activation of pro-
inflammatory genes by altered redox signaling pathways will eventually lead to inflamed 
tissues and organs. Accordingly, molecular inflammation is an important biological 
component of aging. In this perspective, nuclear factor of kappa light polypeptide gene 
enhancer in B-cells (NF-kǃ) is a transcription factor that plays a pivotal role in modulating 
cellular signaling of oxidative stress-induced molecular inflammation. For example, 
stimulus-mediated phosphorylation and the subsequent proteolytic degradation of nuclear 
factor of kappa light polypeptide gene enhancer in B-cells inhibitor (Ikǃ) allows the release 
and nuclear translocation of NF-κB, where transactivates several target genes such as 
forkhead box (FOXO), IL-l┚, IL-6, TNF┙, adhesion molecules, cyclooxygenase-2 (COX-2) and 
nitric oxide synthases inducible (iNOS), all key players in inflammation. 
Aging is associated with activation of both the innate and the adaptive immune system. As 
mentioned above, during aging increased blood levels of proinflammatory cytokines such as 
IL-6 and TNFa can be observed. In healthy elderly populations, high circulating levels of 
TNFa and IL-6 predict mortality, in a manner independent from comorbidity (Bruunsgaard 
& Pedersen, 2003).  
Addionally, an inflammatory response appears to be the prevalent triggering mechanism 
driving tissue damage associated with different age-related diseases and the definition of 
"inflamm-aging" has been coined to explain the underlining inflammatory changes common 
to most age-associated diseases (Licastro et al. 2005). 
Finally, reduced glutathione (GSH) is a major intracellular non-protein -SH compound and 
is accepted as the most important intracellular hydrophilic antioxidant (Melov, 2002). 
Glutathione system is the most important endogenous defense system against oxidative 
stress in body. Under oxidative conditions GSH is reversibly oxidized to glutathione 
disulfide (GSSG). A recent study on age-related changes in GSH in rat brain suggests a 
significant age-related reduction in the GSH level in all regions of the brain, associated with 
an increase in GSH oxidation to GSSG and decrease in the GSH/GSSG ratio (Zhu et al., 
2006). 
4. Methods for analysis of biological aging 
The aging research requires multi- and transdisciplinary approaches and new high-
throughput technologies are continually in development, increasing exponentially the 
amount of biological informations in aging research and elucidating complex unknown 
mechanisms. Although there have been extraordinary advances in study related to gene 
expression, proteomic and functional data, one challenge in aging research is to bring 
together this large variety of data that are still fragmented. Here, we provide a brief 
description of the main technological approaches for biomarkers discovery and for 
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analyzing the  molecular and cellular changes involved in aging cells. We also describe the 
major databases, computational tools and bioinformatics methods that are available in 
biogerontology for data interpretation of the aging phenotypes.  
Analysis of gene-expression data has led to remarkable progress in many biomedical 
disciplines, including gerontology. Numerous methods have been developed for this 
analysis, but the emergence of high-throughput expression profiling and sequencing, such 
as microarray technology (Blalock et al., 2003) or more recently next-generation sequencing 
RNA-Seq have become diffusely used leading to breakthroughs in the investigations of 
aging (Twine et al., 2011). The application of microarray technology to gerontological 
studies has improved our understanding of mechanisms of aging (Golden & Melov, 2007) 
allowing to elucidate molecular differences associated with aging and to scan the entire 
genome for genes that change expression with age. The core principle of a microarray 
experiment is the hybridization of RNA/DNA strands of at least two different conditions, 
such as normal and disease or different ages, with a microarray chip. Briefly, the data 
collection is followed by bioinformatics analysis that require background noise subtraction, 
normalization and identification of statistically significant changes with dedicated software 
packages that calculate through multiple statistical measurements the significance for each 
gene. Ultimately, an application of transcriptomic microarray reported the first assessment 
of age-related alterations in gene expression in a large population-based cohort suggesting 
that modification of messenger RNA (mRNA) processing may comprise an important 
feature of human aging (Harries et al., 2011). In addition, an example of differential 
expression analysis in aging is the comparison of Ames dwarf mice Prop1df/df versus 
Prop1+/+and Little mice Ghrhrlit/lit versus Ghrhr+/lit (Amador-Noguez et al., 2004). In both 
cases, the mutants show delayed aging with significantly increased lifespan and the authors 
found 1125 and 1152 differentially expressed genes in these mutants, respectively, using 
analysis of variance (ANOVA). There is a growing number of age-related molecular 
repositories and one database of gene expression profiles during aging is the Gene Aging 
Nexus, which features a compilation of aging microarray data and microarray datasets 
across different platforms and species (http://gan.usc.edu/) (Pan et al., 2007).  
The genomic convergence approach is a new powerful method  alternative to genome-wide 
association studies that combines trascriptional profiling, expression of quantitative trait 
mapping and gene association. Briefly, microarray technology are used to identify genes 
that show age-related changes in expression. In the next step single nucleotide 
polymorphisms (SNPs) are tested for association with the expression of age-regulated genes 
and finally the expression of quantitative trait loci (eQTLs) are tested for association with a 
phenotype of aging (Wheeler et al., 2009). 
Currently, basic methods to understand biological processes and to identify possible 
candidate biomarkers for a specific pathology are shifted toward “omics“ approaches, 
where all classes of biological compounds can be analyzed by respective ”omic“ techniques. 
To date, proteomic investigations have special relevance to aging-related research since 
altered protein interactions may have a key role in aging-related diseases. Different 
proteomic technology platforms were applied to define the proteomes and conventional 
techniques as two-dimensional gel electrophoresis (2DE), surface-enhanced laser 
desorption/ionization (SELDI), liquid chromatography-mass spectrometry (LC-MS), 
capillary electrophoresis (CE) coupled to mass spectrometry (CE-MS) and protein arrays are 
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also associated to aging related studies. The proteomic analysis require adequate tools for 
data analysis and there are several bioinformatic approaches in proteomics. Many 
algorithms have now been designed to handle the increasing amount of data that are 
available thanks to proteomic analysis and numerous computational approaches and 
software tools have been developed to automatically assign candidate peptide sequences to 
fragment ion spectra, for example, SEQUEST, MASCOT or ProteinProspector. In addition, 
quantitative proteomics based on stable isotope labeling, such as isotope-coded affinity tags 
(ICAT) or stable isotope labeling by amino acids in cell culture (SILAC) represents a 
promising approach for aging studies providing important information to interpret protein 
biomarkers of age-related disease (Zhang et al., 2005). The investigation of changes in 
metabolite fluxes or the analysis of all metabolites in high-throughput fashion, called 
metabolomics (or metabonomics), is an attractive and expanding field in aging research. 
One goal of the metabolomics is to assess the impact of metabolite concentrations on aging 
phenotyope. Several studies have emerged with metabolomics approach traditionally using 
nuclear magnetic resonance (NMR) and recently MS techniques. An example of the 
application of MS-based  metabolomics in aging research is given by Lawton et al. which 
analyzed the plasma of 269 individuals and discovered that age significantly altered the 
concentrations of over 100 metabolites (Lawton et al., 2008). 
In addition,  there are available for metabolomics researchers interested in aging databases 
for metabolite identification, such as METLIN that contains information on metabolites, as 
well as MS data (http://metlin.scripps.edu/) or The Human Metabolome Database 
(http://www.hmdb.ca/) with information on small molecule human metabolites. 
Taking into account that the human aging phenotype is a highly polygenic trait which 
involves changes in genes involved in multiple processes and results from a combination of 
different factors, systems biology approach is particularly powerful in studies of aging. To 
date it seems to be the only method able to define and connect the large volumes of 
experimental data generated by “omics“ fields. The final aim of the systems biology of aging 
is to generate an integrative approach which elucidates the molecular mechanisms of aging 
and to characterize this phenotype at systemic/organism level. In addition to quantify and 
integrate data produced by high-throughput technologies, the systems biology approach 
combines data-driven modelling and hypothesis-driven experimental studies in order to 
link aging phenotypes and its causes. One area in which sistems biology can be applied to 
aging research is the generation of a conceptual whole cell model that considers the dynamic 
behaviors of cellular metabolism. The whole cell representation is structured into subcellular 
entities not only connected by protein-protein interactions but also by process related  to 
metabolism, oxidative stress or trascriptional regulation. The goal of aging cell modelling is 
to build a conceptual framework through the simulation of  dynamic system and to make 
predictions about the aging phenotype. The systems biology community has developed 
tools and modeling platforms to facilitate the representation of metabolic and signaling 
pathways among biological processes and allowing the understanding of complex 
phenomena such as aging. Systems Biology Markup Language (SBML) is the main language 
for coding biological models and currently there are two softwares that support 
construction of models in SMBL, CellDesigner and JDesigner (Oda et al., 2005). Recently, by 
using SBML, McAuley et al. generated an in silico brain aging model which may help to 
predict aging-related brain changes in older people (McAuley et al., 2009). Most of genes 
and proteins exert their functions within a complex network of interactions and another 
applications of systems biolgy is the assemblage of interactomes. The building of interaction 
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networks allow to define changes in interaction of proteins implicated in aging process that 
are involved in maintaining the integrity of the human genome. In the protein-protein 
interaction (PPI) networks, each protein is a node and each interaction an edge and the first 
attempt towards constructing a “human longevity network” via analysis of human PPIs was 
made by Budovsky et al. in 2007 (Budovsky et al., 2007). According to the BioGrid database, 
the authors constructed  a “core longevity network” that comprises 153 longevity-associated 
proteins and 33 non-longevity-associated proteins that have connections with at least five 
longevity-associated proteins or more. Therefore, network-based approaches are notably 
valuable for deciphering complex biological systems providing insights about aging, 
longevity and age-related disease. In addition, there are several collections of online 
resources available for biogerontologists that can also serve for the visualization of protein-
protein interactions. Databases focused on genes related to aging and/or longevity include 
GeneAge and AnAge featured by the Human Aging Genomic Resources 
(http://genomics.senescence.info/) that is a collection of databases and tools designed for 
understanding the genetics of human aging. GeneAge is a curated reference database of 
different searchable data sets of genes associated with the human aging phenotype. One 
possible approach of GeneAge is the visualizzation of protein-protein interactions with one 
or more genes as query but additional ways can be used to build genes and protein 
interaction networks in  conjunction with data stored in interaction databases such as IntAct 
(Kerrien et al., 2007). There is an expanding number of age-related repositories, such as 
NetAge (http://netage-project.org/) which provides information on microRNA-regulated 
protein-protein interaction networks that are involved in aging and related processes. 
Furthermore, one gene expression database is AGEMAP (Zahn et al., 2007), which allows  to 
analize multiple genes and mechanisms affect aging decribing changes in expression levels 
in different mouse tissues. Finally, one database on human aging which will be available to 
the public is MARK-AGE (http://www.mark-age.eu/), a large-scale integrated project 
supported by the European Community. The aim of this project is to conduct a population 
study in order to identify a set o biomarkers of aging.  
The coordinate assessment of genotypes, trascriptional and proteomic profiles in association 
with system and computational biology strategies will be able to reach a comprehensive 
model for the study of human aging and longevity  but also for healthy aging. 
5. Conclusion 
Biomarkers of aging are an hot topic and have the ability to improve our life. Various 
parameters are directly affected and altered during aging and several indicators are being 
used to evaluate the aging process. However, not all can be used as biomarker of aging 
because many of them are influenced by different factors such as diet, enviroment or type of 
tissue. In addition, some biomarkers are dependent by the methods used to measure them. 
Accordingly, there is not yet a “pure” biomarkers of aging and  the markers discussed are 
related not only to age but also to disease.  
Furthermore, it is a subject of debate whether the determination of biological age markers is 
really addressing aging itself, or if it indicates stress induced acceleration of the age process 
by exogenic factors. 
Aging is a multi-dimensional process and these biomarkers could be used to monitor and 
identify the development of age-associated disease providing new anti-aging strategies. 
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7. Abbreviations 
The abbreviations used are: CVD, cardiovascular diseases; DCs, dendritic cells; NK, natural 
killer; RTE, thymic emigrants; IL-1ǃ, Interleukin-1ǃ; IL-6, Interleukin-6; IFNǄ, interferon Ǆ; 
TNFǂ, tumor necrosis factor ǂ; HSC, hematopoietic stem cell; SA-ǃ-gal, Senescence-
Associated ǃ-galactosidase; ROS, reactive oxygen species; SSBs, single-strand breaks; DSBs, 
double-strand breaks; IR, infrared; p16INK4a or CDKN2A, cyclin-dependent kinase inhibitor 
2A; TP53, tumor protein 53;MGMT,O6-methylguanine-DNAmethyltransferase;8-OHdG,8-
hydroxy-29 deoxyguanosine; MDA, malondialdehyde; HNE, 4-hydroxy-2-nonenal; LDL, 
low-density lipoproteins; PCOOH, phosphatidylcholine hydroperoxides; IsoPs, 
isoprostanes; NF-kǃ, nuclear factor of kappa light polypeptide gene enhancer in B-cells; Ikǃ, 
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor; FOXO, forkhead 
box; COX-2, cyclooxygenase-2; GSH, reduced glutathione; GSSG, glutathione disulfide; 
mRNA, messenger RNA; SNPs, single nucleotide polymorphisms; eQTLs, expression of 
quantitative trait loci; 2DE, two-dimensional gel electrophoresis; SELDI, surface-enhanced 
laser desorption/ionization; MS, mass spectrometry; LC, liquid chromatography; CE, 
capillary electrophoresis; NMR, nuclear magnetic resonance; SBML, Systems Biology 
Markup Language; PPI, protein-protein interaction. 
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